The high cost of false positive blood cultures

The false positive blood culture costs to hospitals are high. Likewise, the unnecessary treatment of a suspected bloodstream infection can have serious negative clinical consequences for patients.

The financial cost of false positive blood cultures

  • Major healthcare payers no longer reimburse hospital-acquired infections.
  • The cost of a false-positive blood culture is estimated at $4,500-$10,000.1
  • With 1/3 of all positive blood culture results being inaccurate, the average hospital spends more than $1 million dollars on unnecessary treatment of non-existent bloodstream infections.
  • Each year, U.S. hospitals waste several billion dollars related to more than one million false-positive results.

The clinical cost of false positive blood cultures

  • Extended hospital stays increase the risk of hospital-acquired infections and adverse events.
  • The unnecessary administration of antibiotics increases the risk of allergic reactions and drug interactions.
  • The overuse of antibiotics lessens the efficacy of treatment and leaves patients vulnerable to drug-resistant superbugs.
  • The discomfort, inconvenience, and anxiety caused by undergoing unnecessary bloodstream infection treatment lowers patient satisfaction scores.

It is time to lower false positive blood cultures costs and improve the accuracy of blood culture results with Kurin.